- Home
- KPRX vs AREB Comparison
KPRX vs AREB Comparison
Compare KPRX & AREB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- AREB
- Stock Information
- Founded
- KPRX 1998
- AREB 2014
- Country
- KPRX United States
- AREB United States
- Employees
- KPRX N/A
- AREB N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- AREB Plastic Products
- Sector
- KPRX Health Care
- AREB Industrials
- Exchange
- KPRX Nasdaq
- AREB Nasdaq
- Market Cap
- KPRX 9.1M
- AREB 10.4M
- IPO Year
- KPRX N/A
- AREB N/A
- Fundamental
- Price
- KPRX $2.90
- AREB $1.42
- Analyst Decision
- KPRX Strong Buy
- AREB
- Analyst Count
- KPRX 1
- AREB 0
- Target Price
- KPRX $10.00
- AREB N/A
- AVG Volume (30 Days)
- KPRX 1.3M
- AREB 1.2M
- Earning Date
- KPRX 08-08-2025
- AREB 08-13-2025
- Dividend Yield
- KPRX N/A
- AREB N/A
- EPS Growth
- KPRX N/A
- AREB N/A
- EPS
- KPRX N/A
- AREB N/A
- Revenue
- KPRX $20,000.00
- AREB $9,887,755.00
- Revenue This Year
- KPRX N/A
- AREB N/A
- Revenue Next Year
- KPRX N/A
- AREB N/A
- P/E Ratio
- KPRX N/A
- AREB N/A
- Revenue Growth
- KPRX N/A
- AREB N/A
- 52 Week Low
- KPRX $2.51
- AREB $1.10
- 52 Week High
- KPRX $4.86
- AREB $231.75
- Technical
- Relative Strength Index (RSI)
- KPRX 43.33
- AREB 36.40
- Support Level
- KPRX $2.87
- AREB $1.35
- Resistance Level
- KPRX $3.22
- AREB $1.48
- Average True Range (ATR)
- KPRX 0.18
- AREB 0.14
- MACD
- KPRX -0.02
- AREB 0.07
- Stochastic Oscillator
- KPRX 5.77
- AREB 8.64
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic product areas using a wholesale distribution network, utilizing personal appearances, musical venue performances, as well as e-commerce and television. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, jackets, coats, and Others. The Company views its operations and manages its business as one operating segment engaged in patriotic goods, comprised of safes, soft goods, and beer.